Skip to main content
New patient offer

Your first month, already discounted

New patients pay a reduced price for the first month of a compounded GLP-1 program. The discount is applied automatically at checkout, so there is no code to find or paste. Each program includes an online consultation with a licensed provider and, if prescribed, your medication with vitamin B12, injection supplies, overnight shipping and provider messaging.

Treatment requires provider approval and is intended for adults with a BMI of 25 or higher. Results vary. See eligibility below.

New patients, monthly plan

Semaglutide + B12

$79 first month

Regular price from $103/month after your first month. Cancel any time.

Start this program
New patients, monthly plan

Tirzepatide + B12

$99 first month

Regular price from $128/month after your first month. Cancel any time.

Start this program
What is included
  • Online consultation with a licensed provider
  • Compounded medication with vitamin B12, if prescribed
  • Injection supplies and a step-by-step dosing guide
  • Overnight UPS Next Day Air shipping, temperature-controlled
  • Unlimited provider messaging during treatment
  • No membership, consultation or pharmacy fees

Questions

Do I need a code for the first-month price?

No. New patients get the first-month price automatically on the monthly plan. There is nothing to type and nothing to copy.

What happens after the first month?

The monthly plan renews at the regular price for your dose, from $103 for semaglutide and $128 for tirzepatide, unless you cancel. Cancel any time from your patient portal or by messaging support before your next billing date.

What does the price include?

An online consultation with a licensed provider and, if prescribed, your medication with vitamin B12, injection supplies, a dosing guide, overnight shipping and provider messaging. There are no separate consultation or pharmacy bills.

What if the provider does not approve me?

You are not charged for the program. A licensed provider reviews every intake and decides whether treatment is appropriate.

Who is eligible?

Adults with a BMI of 25 or higher. Semaglutide and tirzepatide cannot be prescribed to people with type 1 diabetes, a personal or family history of medullary thyroid cancer or MEN2, pancreatitis, gallbladder disease, an eating disorder, diabetic retinopathy, a serious gastrointestinal disorder, bariatric surgery in the last 6 months, or who are pregnant, breastfeeding or planning pregnancy. Your provider decides during the consultation.

Compounded medications are prepared by licensed US pharmacies for individual patients and are not FDA-approved. Questions? Contact us.